Actinium Pharmaceuticals Reports New Hires to Product Development and Clinical Research Teams

Actinium Pharmaceuticals, Inc. (NYSEMKT:ATNM) announced the appointment of Rowena Choudrie, M.S. to the position of Senior Director, Pharmaceutical Product Development and Kevin Zikaras to the position of Senior Clinical Scientist. These hires will report to Kaushik J. Dave, Ph.D., MBA Chief Executive Officer and Felix Garzon, M.D., Ph.D., Senior Vice President, Head of Clinical Development, respectively.

Sandesh Seth, Executive Chairman of Actinium Pharmaceuticals commented:

Actinium has strategically added to our team in recent months reflecting the progress we have made with our Iomab-B and Actimab-A programs, which will both be in later stage clinical trials this year. The hiring of Rowena and Kevin is a display of our ability to attract top talent and I look forward to their contributions to our goal of developing and commercializing best in class therapies for diseases with unmet needs.

Click here to view the full press release.